BioHealth News Archive
Baltimore-based AsclepiX Therapeutics raises $5M – Technical.ly Baltimore
Johns Hopkins spinout AsclepiX Therapeutics raised $5 million in new funding that will assist in development of new treatment for eye diseases that are…
Read More
2019 California Life Sciences Industry Report – California Life Sciences Association
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, and PwC US, are proud to release the 2019 California Life…
Read More
5 Telehealth Insights from CMS’ Seema Verma – HealthLeaders Media
Telehealth is changing the face of healthcare, and Medicare must adapt, said the CMS administrator. Innovation is vital to the evolution and sustainability of…
Read More
TEDx Amplifies UMB’s Cutting-Edge Innovations – University of Maryland, Baltimore
The audience seated in an intimate ballroom at the University of Maryland, Baltimore (UMB) on Nov. 9 turned its attention to a small stage…
Read More
Opportunities in genomic testing and precision medicine – McKinsey
Advanced analysis of genomic data integrated with electronic medical records and other data sets, combined with effective reimbursement strategies and full data-regulatory compliance, will…
Read More
HISTORIC DAY: Virginia Tech Innovation Campus key to Virginia attracting Amazon HQ2 – Virginia Tech
Virginia emerged as a winner in the fierce, nationwide competition to house a headquarters for Amazon. The commonwealth stepped up with a standout higher…
Read More
Rexahn Pharmaceuticals Announces Leadership Transition – Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve outcomes in cancers that are difficult to treat,…
Read More
SERAXIS Inc. publishes clinical trial considerations for a type 1 diabetes stem cell-derived therapy
SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial considerations for SR-01, its pluripotent stem cell-derived islet therapy…
Read More
CRISPR, MaxCyte expand partnership into immuno-oncology – Pharmaceutical Business review
Gene editing company CRISPR Therapeutics and cell-based medicines and life sciences firm MaxCyte have expanded clinical and commercial license agreement into oncology. {iframe}https://www.pharmaceutical-business-review.com/news/crispr-maxcyte-expand-partnership-to-develop-immuno-oncology-therapies/{/iframe}
Read More
A Win for the Region, A Win for Montgomery County
Today’s announcement that Amazon has selected New York City and Arlington, Virginia, as the locations for the company’s new headquarters is a win for Montgomery County. Amazon will invest $5…
Read More
The Squeeze Continues…Early Stage Health Tech Deal Volume Falls to New Lows – LinkedIn
Groundhog Day? This month, Forbes reported that venture capital investments in healthcare startups hit record highs, despite the infamous dissolution of Theranos. While this…
Read More
Biobuzz Directory – NextCure Raises $93 Million Investment on Heels of Eli Lilly Immune-Oncology Deal
NextCure Inc., a privately-held biopharmaceutical company discovering and developing the next generation of immunomedicines for cancer and other diseases, today announced the completion of…
Read More
A Tale Of Two Cities: Amazon Picks NYC, Northern Virginia For New HQ
After a highly competitive site selection process that had communities across the U.S. touting their qualifications, Amazon has selected New York City and Arlington,…
Read More
3 Business Models That Could Bring Million-Dollar Cures to Everyone
When the FDA issued its first approval for a gene therapy for an inherited disease nearly a year ago—a cure for a type of…
Read More
Amazon Picks New York City, Northern Virginia for Its HQ2 Locations – WSJ
New York City and Northern Virginia will be the homes for Amazon.com Inc.’s second and third headquarters, according to people familiar with the matter,…
Read More